Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)-malononitrile], Inhibits Cell Growth by Disrupting Mitochondria

Cancer Research

Volumn 55, Issue 13, 1995, Pages 2794-2799

  Burger, Angelika M ^a   Kaur, Gurmeet ^b   Alley, Michael C ^b   Supko, Jeffrey G ^b   Malspeis, Louis ^b   Grever, Michael R ^b   Sausville, Edward A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; OLIGOMYCIN; PROTEIN TYROSINE KINASE INHIBITOR; RHODAMINE 123; TYRPHOSTIN;

ARTICLE; BRAIN CANCER; BREAST CARCINOMA; CANCER CONTROL; CELL STRAIN HL 60; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LEUKEMIA CELL; LUNG CARCINOMA; MELANOMA; MITOCHONDRION; OVARY CARCINOMA; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; CELL DIVISION; GROWTH INHIBITORS; HUMAN; IN VITRO; INTRACELLULAR MEMBRANES; MITOCHONDRIA; NITRILES; PERMEABILITY; PHENOLS; PROTEIN-TYROSINE KINASE; RHODAMINE 123; RHODAMINES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029034225     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gazit, A., Yaish, P., Gilon, C., and Levitzki, A. Tyrphostins 1: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem., 32: 2344–2362, 1989.
2. Levitzki, A. Tyrphostins—potential antiproliferative agents and novel molecular tools. Biochem. Pharmacol., 40: 913–918, 1990.
3. Levitzki, A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J., 6: 3275–3282, 1992.
4. Levitzki, A., Gazit, A., Osherov, N., Posner, I., and Gilon, C. Inhibition of protein-tyrosinc kinases by tyrphostins. Methods Enzymol., 201: 347–361, 1991.
5. Gillespie, J., Dye, J. F., Schachter, M., and Guillou, P. J. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors. Br. J. Cancer, 68: 1122–1126, 1993.
6. Anafi, M., Gazit, A., Gilon, C., Ben-Neriah, Y., and Levitzki, A. Selective interactions of transforming and normal abl proteins with, ATP tyrosine-copolymer substrates and tyrphostins. J. Biol. Chem., 267: 4518–4523, 1992.
7. bcr-abl autokinase acitivity in K562 chronic myelogenous leukemia. Anticancer Drugs, 5: 213–222,1994.
8. Supko, J. G., Malspeis, L., Sausville, E. A., Burger, A., Alley, M., and Grever, M. R. Identification of the antitumor activity and preclinical evaluation of the benzyliden-emalononitrile derivative NSC 242557. Proc. Am. Assoc. Cancer Res., 35:424,1994.
9. Bilder, G. E., Krawiec, J. A., McVety, K., Gazit, A., Gilon, C., Lyall, R., Zilberstein, A., Levitzki, A., Perrone, M. H., and Schreiber, A. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol., 260: C721–C730, 1991.
10. Levitzki, A., and Gilon, G. Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol. Sci., 12: 171–173, 1991.
11. Lander, H. N., Levine, D. M., and Novogrodsky, A. Agonistic effects of tyrphostins on human peripheral mononuclear cells. Cell. Immunol., 144: 155–168, 1992.
12. Freisleben, H. J., Fuchs, J., Mainka, L., and Zimmer, G. Reactivity of mitochondrial sulfhydryl groups toward dithionitrobenzoic acid and bromobimanes under oligomy-cin-inhibited and uncoupling conditions. Arch. Biochem. Biophys., 266: 89–97, 1988.
13. Terada, H., Kumazawa, N., Ju-Ichi, M., and Yoshikawa, K. Molecular basis of the protonophoric and uncoupling activities of the potent uncoupler SF-6847 ((3,5-di-tert-butyl-4-hydroxybenzylidene)malononitrile) and derivatives. Regulation of their electronic structures by restricted intramolecular rotation. Biochim. Biophys. Acta., 767: 192–199, 1984.
14. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48: 589–601, 1988.
15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55–63, 1983.
16. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Pauli, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., and Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 83: 757–766, 1991.
17. DeLuca, M., and McElroy, W. D. Purification and properties of firefly luciferase. Methods Enzymol., 57: 3–15, 1978.
18. Johnson, L. V., Walsh, M. L., Bockus, B. J., and Chen, L. B. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol., 88: 526–535, 1981.
19. Rago, R. P., Brazy, P. C., and Wilding, G. Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU 145 prostate carcinoma cells. Cancer Res., 52: 6953–6955, 1992.
20. Rago, R. P., Mitchen, J., Cheng, A. L., Oberly, T., and Wilding, G. Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res., 57: 6629–6635, 1991.
21. Evermann, J. F., Heeney, J. L., McKeirnan, A. J., and O'Brian, S. J. Comparative features of a coronavirus isolated from a cheetah with feline infectious peritonitis. Virus Res., 75: 15–28, 1989.
22. Lamb, D. J., and Sankararaman, S. Tyrphostins inhibit Sertoli cell-secreted growth factor stimulation of A431 cell growth. Recent Prog. Horm. Res., 48: 511–516,1993.
23. Young, S. W., Poole, R. C., Hudson, A. T., Halestrap, A. P., Denton, R. M., and Tavare, J. M. Effects of tyrosine kinase inhibitors on protein-kinase independent systems. FEBS Lett., 376: 278–282, 1993.